The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Colorectal Cancer Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time
The global Colorectal Cancer Therapeutics market size is expected to reach US$ 17070 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Colorectal Cancer Therapeutics in various end use industries. The expanding demands from the Hospitals, Clinic and Research Institutions,, are propelling Colorectal Cancer Therapeutics market. Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Therapeutics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Colorectal Cancer Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Colorectal Cancer Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Colorectal Cancer Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Colorectal Cancer Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Colorectal Cancer Therapeutics covered in this report include Taiho Pharma, Merck KGaA, Amgen, Takeda, Roche, Eli Lilly, Sanofi, Regeneron and Bayer, etc.
The global Colorectal Cancer Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Bristol-Myers Squib
Sumitomo Dainippon Pharma
Array BioPharma
Hutchison MediPharma
Jiangsu Hengrui Medicine
Jiangsu Chia-Tai Tianqing
Suzhou Zelgen Biopharmaceuticals
Global Colorectal Cancer Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Colorectal Cancer Therapeutics market, Segment by Type:
Diagnostics
Therapeutics
Global Colorectal Cancer Therapeutics market, by Application
Hospitals
Clinic
Research Institutions
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Colorectal Cancer Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time
The global Colorectal Cancer Therapeutics market size is expected to reach US$ 17070 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Colorectal Cancer Therapeutics in various end use industries. The expanding demands from the Hospitals, Clinic and Research Institutions,, are propelling Colorectal Cancer Therapeutics market. Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Therapeutics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Colorectal Cancer Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Colorectal Cancer Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Colorectal Cancer Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Colorectal Cancer Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Colorectal Cancer Therapeutics covered in this report include Taiho Pharma, Merck KGaA, Amgen, Takeda, Roche, Eli Lilly, Sanofi, Regeneron and Bayer, etc.
The global Colorectal Cancer Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Bristol-Myers Squib
Sumitomo Dainippon Pharma
Array BioPharma
Hutchison MediPharma
Jiangsu Hengrui Medicine
Jiangsu Chia-Tai Tianqing
Suzhou Zelgen Biopharmaceuticals
Global Colorectal Cancer Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Colorectal Cancer Therapeutics market, Segment by Type:
Diagnostics
Therapeutics
Global Colorectal Cancer Therapeutics market, by Application
Hospitals
Clinic
Research Institutions
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Colorectal Cancer Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Colorectal Cancer Therapeutics
1.1 Colorectal Cancer Therapeutics Market Overview
1.1.1 Colorectal Cancer Therapeutics Product Scope
1.1.2 Colorectal Cancer Therapeutics Market Status and Outlook
1.2 Global Colorectal Cancer Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Colorectal Cancer Therapeutics Market Size by Region (2018-2029)
1.4 Global Colorectal Cancer Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Colorectal Cancer Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Colorectal Cancer Therapeutics Market Size (2018-2029)
1.6.1 North America Colorectal Cancer Therapeutics Market Size (2018-2029)
1.6.2 Europe Colorectal Cancer Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Colorectal Cancer Therapeutics Market Size (2018-2029)
1.6.4 Latin America Colorectal Cancer Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Colorectal Cancer Therapeutics Market Size (2018-2029)
2 Colorectal Cancer Therapeutics Market by Type
2.1 Introduction
2.1.1 Diagnostics
2.1.2 Therapeutics
2.2 Global Colorectal Cancer Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Colorectal Cancer Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Colorectal Cancer Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Colorectal Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Colorectal Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Colorectal Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Colorectal Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Colorectal Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
3 Colorectal Cancer Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinic
3.1.3 Research Institutions
3.2 Global Colorectal Cancer Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Colorectal Cancer Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Colorectal Cancer Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Colorectal Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Colorectal Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Colorectal Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Colorectal Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Colorectal Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
4 Colorectal Cancer Therapeutics Competition Analysis by Players
4.1 Global Colorectal Cancer Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Colorectal Cancer Therapeutics as of 2022)
4.3 Date of Key Players Enter into Colorectal Cancer Therapeutics Market
4.4 Global Top Players Colorectal Cancer Therapeutics Headquarters and Area Served
4.5 Key Players Colorectal Cancer Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Colorectal Cancer Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Taiho Pharma
5.1.1 Taiho Pharma Profile
5.1.2 Taiho Pharma Main Business
5.1.3 Taiho Pharma Colorectal Cancer Therapeutics Products, Services and Solutions
5.1.4 Taiho Pharma Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Taiho Pharma Recent Developments
5.2 Merck KGaA
5.2.1 Merck KGaA Profile
5.2.2 Merck KGaA Main Business
5.2.3 Merck KGaA Colorectal Cancer Therapeutics Products, Services and Solutions
5.2.4 Merck KGaA Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Merck KGaA Recent Developments
5.3 Amgen
5.3.1 Amgen Profile
5.3.2 Amgen Main Business
5.3.3 Amgen Colorectal Cancer Therapeutics Products, Services and Solutions
5.3.4 Amgen Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Takeda Recent Developments
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business
5.4.3 Takeda Colorectal Cancer Therapeutics Products, Services and Solutions
5.4.4 Takeda Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Takeda Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Colorectal Cancer Therapeutics Products, Services and Solutions
5.5.4 Roche Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Profile
5.6.2 Eli Lilly Main Business
5.6.3 Eli Lilly Colorectal Cancer Therapeutics Products, Services and Solutions
5.6.4 Eli Lilly Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly Recent Developments
5.7 Sanofi
5.7.1 Sanofi Profile
5.7.2 Sanofi Main Business
5.7.3 Sanofi Colorectal Cancer Therapeutics Products, Services and Solutions
5.7.4 Sanofi Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Sanofi Recent Developments
5.8 Regeneron
5.8.1 Regeneron Profile
5.8.2 Regeneron Main Business
5.8.3 Regeneron Colorectal Cancer Therapeutics Products, Services and Solutions
5.8.4 Regeneron Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Regeneron Recent Developments
5.9 Bayer
5.9.1 Bayer Profile
5.9.2 Bayer Main Business
5.9.3 Bayer Colorectal Cancer Therapeutics Products, Services and Solutions
5.9.4 Bayer Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Bayer Recent Developments
5.10 Onyx
5.10.1 Onyx Profile
5.10.2 Onyx Main Business
5.10.3 Onyx Colorectal Cancer Therapeutics Products, Services and Solutions
5.10.4 Onyx Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Onyx Recent Developments
5.11 Bristol-Myers Squib
5.11.1 Bristol-Myers Squib Profile
5.11.2 Bristol-Myers Squib Main Business
5.11.3 Bristol-Myers Squib Colorectal Cancer Therapeutics Products, Services and Solutions
5.11.4 Bristol-Myers Squib Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Bristol-Myers Squib Recent Developments
5.12 Sumitomo Dainippon Pharma
5.12.1 Sumitomo Dainippon Pharma Profile
5.12.2 Sumitomo Dainippon Pharma Main Business
5.12.3 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Products, Services and Solutions
5.12.4 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Sumitomo Dainippon Pharma Recent Developments
5.13 Array BioPharma
5.13.1 Array BioPharma Profile
5.13.2 Array BioPharma Main Business
5.13.3 Array BioPharma Colorectal Cancer Therapeutics Products, Services and Solutions
5.13.4 Array BioPharma Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 Array BioPharma Recent Developments
5.14 Hutchison MediPharma
5.14.1 Hutchison MediPharma Profile
5.14.2 Hutchison MediPharma Main Business
5.14.3 Hutchison MediPharma Colorectal Cancer Therapeutics Products, Services and Solutions
5.14.4 Hutchison MediPharma Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.14.5 Hutchison MediPharma Recent Developments
5.15 Jiangsu Hengrui Medicine
5.15.1 Jiangsu Hengrui Medicine Profile
5.15.2 Jiangsu Hengrui Medicine Main Business
5.15.3 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Products, Services and Solutions
5.15.4 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.15.5 Jiangsu Hengrui Medicine Recent Developments
5.16 Jiangsu Chia-Tai Tianqing
5.16.1 Jiangsu Chia-Tai Tianqing Profile
5.16.2 Jiangsu Chia-Tai Tianqing Main Business
5.16.3 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Products, Services and Solutions
5.16.4 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.16.5 Jiangsu Chia-Tai Tianqing Recent Developments
5.17 Suzhou Zelgen Biopharmaceuticals
5.17.1 Suzhou Zelgen Biopharmaceuticals Profile
5.17.2 Suzhou Zelgen Biopharmaceuticals Main Business
5.17.3 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Products, Services and Solutions
5.17.4 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.17.5 Suzhou Zelgen Biopharmaceuticals Recent Developments
6 North America
6.1 North America Colorectal Cancer Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Colorectal Cancer Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Colorectal Cancer Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Colorectal Cancer Therapeutics Market Dynamics
11.1 Colorectal Cancer Therapeutics Industry Trends
11.2 Colorectal Cancer Therapeutics Market Drivers
11.3 Colorectal Cancer Therapeutics Market Challenges
11.4 Colorectal Cancer Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
